Nebulized Fentanyl Matches IV Morphine at 15 Minutes in Small ED Trial
This small single-center double-dummy trial gives pain pharmacists early adult data on a non-invasive opioid route for severe musculoskeletal pain, but its sample size, 60-minute window, and narrow population limit practice application.
📅 Journal publication: Jul 24, 2026·Last updated: Nov 16, 2026
Nebulized fentanyl competes with intravenous morphine for acute pain relief in the ER.
Emergency departments seek effective, non-invasive pain management alternatives to intravenous morphine. Nebulized fentanyl and intravenous morphine showed similar pain reduction at 15 minutes in acute pain patients. Findings suggest nebulized fentanyl is a viable alternative; however, small sample size limits generalizability. Nebulized fentanyl may offer a non-invasive alternative to intravenous morphine in emergency settings.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.